Amedi.sk
Dovoľujeme si Vás upozorniť, že naša web stránka
je určená iba pre odbornú lekársku verejnosť.
Časopis Neurology – Článok Invasive meningococcal diseases in the Slovak Republic in 2015

Neurology

Reviewed, postgraduate scietific medical journal.
Period 3x per year
1336-8621
The journal is indexed in the Slovak National Bibliography, Bibliographiia Medica Slovaca (BMS) and listed to citation database CiBaMed. All articles are reviewed. The publisher does not bear any responsibility for data and opinions of particular authors of the articles or advertisements. The articles on grey pages are company promotions or non reviewed information, an author is responsible for the content. Any reproduction of the content is allowed only with direct consent of the editorial office.
Predplatné
Neurology
Neurology
Reviewed, postgraduate scietific medical journal.
Period 3x per year
Téma: Original works

Invasive meningococcal diseases in the Slovak Republic in 2015

Anna Kružlíková, Viera Jančulová

Invasive meningococcus infections are despite the advance in medicine still serious, life-threatening conditions.
Aim of the work: Phenotypisation and genotypisation identifications of N. meningitidis strains, which caused invasive meningococcus
diseases (IMD) and identification of nasopharyngeal carrier strains in the SR in 2015. Testing of quantitative sensitivity
(MIC) of N. meningitidis against selected ATB. The epidemiological analysis of IMD sensitivity incidence in the SR in
2015. Overview of actual vaccination substances in the SR for IMD prevention. The aim of the work was also to publish general
knowledge on IMD as about their originator N. meningitidis, laboratory diagnostics, epidemiology, clinical picture, ATB
therapy and prophylaxis.
Methods: A mount stained according to Gram was prepared from each biological material for light microscopy. Biochemical
– metabolic properties of bacterial isolates from the liquor, blood and pathological material we verified with commercial diagnostic
sets (Erba Lachema). To determine a serogroup we used agglutination with specific antisera (Becton&Dickinson) and
PCR. PCR also helped to prove a molecular type identification. Minimal inhibitory concentration (MIC) of benzylpenicillin (PNC),
cefotaxim (CTX), ciprofloxacin (CIP), rafimpicin (RIF) we detected with E-tests (Liofilmchem s.r.l.). Antibiotic sensitivity was
evaluated according to present break-points for MIC and inhibition zone interpretation (European Committee on Antimicrobial
68 Neurológia 2/2016
PôVODNÉ PRÁCE
Susceptibility Testing – EUCAST). Into the work there were involved results of the NRC laboratory for meningococci, molecular
biology laboratories (the Department for medical microbiology, UVZSR, Bratislava), reporting of disease cases into EPIS in cooperation
with the department of epidemiology.
Results: In the Slovak Republic in 2015 there were altogether 30 invasive meningococcal diseases (IMD). From these 30 cases
26 were laboratory confirmed, 4 ended in death – 1 x N. meningitidis C serogroup in a 2-year old child, 2 x N. meningitidis of
the B serogroup in 8-month old and 1-year old child. In a 5-month old child the cultivation examination of liquor was negative.
Clinically 17x it was meningitis, in other cases sepsis or meningitis with sepsis. The disease incidence was sporadic prevailingly,
two diseases occurred in one family. The group serotypisation of meningococci was done in 23 patients (76.67%). The serogroup
B prevailed (15x), 4x serogroup C, in 4 patients the group was not determined. In NRC for meningococci 315 carrier
strains of N. meningitidis were analysed: 145 from the serogroup B (46%), 8 strains from the serogroup C (2%), 24 strains of the
serogroup Y (8 %), 10 strains of the serogroup W135 (3%) and 15 strains of the serogroup 29E (5%). From 2 materials N. meningitidis
of the serogroup X was identified (1%). In 111 (35%) of carrier strains the serogroup was not detected. In 2015 and until
the end of April 2016 we noticed 3 resistant strains (MIC PNC – 0.75 mg/L – liquor, 0.38 mg/L – tonsils, 0.75 mg/L – nose,) and
23 strains of N. meningitidis with threshold sensitivity against PNC. Resistant strains were betalactam-negative.
Conclusion: In comparison with previous years 2014 (29 IMD) and 2013 (25 IMD), the number of diseases caused by N. meningitidis
does not differ significantly from 2015 (30). Compared with 2012 morbidity decreased by 26.83%. In the strains N. meningitidis
from IMD the predominance of serogroup B incidence over C was present during the whole monitored period. To prevent
the disease in the Slovak Republic there are available following vaccination substances with the valid registration:
1. conjugated polysaccharide vaccines - Meningococcal A+C (Sanofi Pasteur), NeisVacC (Pfizer), Nimenrix (Pfizer)
2. a conjugated oligosaccharide vaccine – Menveo (GSK Vaccines S.r.l.),
3. a component adsorbed vaccine – Bexsero (Novartis Vaccines and Diagnostics S.r.l).

Neurológia 2016; 11 (2): 67-73
CELÝ OBSAH ČLÁNKU JE DOSTUPNÝ IBA PRE PRIHLÁSENÝCH PREDPLATITEĽOV Prihlásiť sa

Témy časopisu Neurology 2 / 2016

Overview works

Case studies

Nie sú dostupné žiadne voľne dostupné články
CHAIRMAN OF THE EDITORIAL BOARD
doc. MUDr. Miroslav Brozman, CSc.

MEMBERS OF THE EDITORIAL BOARD
MUDr. František Cibulčík, CSc.
doc. MUDr. Eleonóra Klímová, CSc.
doc. MUDr. Pavol Kučera, PhD.
MUDr. Marian Kuchar, PhD.
doc. MUDr. Robert Mikulík,Ph.D., FESO
MUDr. Vladimír Nosáľ, PhD.
MUDr. Ľubica Procházková, CSc.
prof. MUDr. Bruno Rudinský, CSc.
doc. MUDr. Daniel Šaňák, Ph.D.
doc. MUDr. David Školoudík, Ph.D., FESO
prof. MUDr. Karel Šonka, DrSc.
doc. MUDr. Peter Špalek, PhD.
Dr. Milan R. Voško, PhD.

EDITOR-IN-CHIEF
Eva Stachová
e-mail: stachova@amedi.sk

GRAPHIC LAYOUT AND TYPESETTING
Lucia Vecseiová
e-mail: dtp@amedi.sk

MARKETING MANAGER
Ing. Dana Lakotová
mobil: 0903 224 625
e-mail: marketing@amedi.sk

ECONOMY AND SUBSCRIPTIONS
Ing. Mária Štecková
telefón: 02/55 64 72 48
mobil: 0911 117 949
e-mail: ekonom@amedi.sk

PROFESSIONAL PROOFREADING
prof. MUDr. Bruno Rudinský, CSc.
PhDr. Eva Flonteková

LANGUAGE PROOFREADING
Mgr. Eva Doktorová

PROOFREADING OF ENGLISH TEXTS
Mgr. Jana Bábelová
SECTIONS

OVERVIEW PAPERS
The latest knowledge on disease and disease groups aetiology, pathogenesis, diagnoses and therapy. Maximum size is 7 pages (font size 12, line spacing 1.5) with maximum 6 pictures (graphs). In case of more extensive theme elaboration it is possible to divide the paper to several parts after agreement with editorial office. Write the article with emphasis on its practical usage for neurologists.

CASE STUDY
Maximum extent is 7 pages. Structuring: summary, introduction, case study, discussion, conclusion, bibliography.

DIAGNOSTIC AND THERAPEUTICAL ALGORITHMS
Diagnosis and therapy processed into tables and schemes, with minimum text, with emphasis on conciseness and clarity.

MISCELLANEOUS
Reaction to overview articles, news in the field of diagnostics, therapy, trial results (maximum 3 pages), reports from professional events, abstracts from scientific work published abroad, not older than 1 year. Maximum extent is 1 page. Write the title of the paper in Slovak/Czech, authors, workplace, then title of the paper in English with full citation.

APPENDIX - GENERAL MEDICINE
Intersectional theme elaborated complexly, well-arranged, clear (extent up to 12 pages).


MANUSCRIPT ELABORATION

Write the paper on computer in any common text editor.
- write full length of lines (do not use ENTER at the end of a line)
- - do not arrange text into columns
- - do not do page make-up, put tables at the end of the paper
- distinguish precisely numbers 1, 0 and letters l, O
- use always parentheses ( )
- explain abbreviations always when first used


MANUSCRIPT REQUIREMENTS

1. An accurate paper title, names and surnames of all authors including titles, authors` workplace. The first author address including the phone number, fax and e-mail address.
2. Summary - concise content summary in the extent maximum 10 lines (only at overview papers, case studies and Appendices - General Medicine). Write in 1st or 3rd person singular or plural (unify according the type of an article).
3. Key words - in the extent of 3-6 (only for overview papers and Appendices - General Medicine).
4. English translation: paper title, summary, key words (only at overview papers, and Appendices - General Medicine)
5. Text
If you insert pictures into a document, send also their original files in "jpg" format, create graphs in Excel and send also their original files. If you send photo documentation via post office, please, send just high-class originals. Mark each original by a number, under which it is mentioned in the text. Write in 1st or 3rd person singular or plural (unify according the type of an article).
6. Bibliography
Citations are numbered chronologically in bold, references in the text are stated by the number of citations in parentheses. Use maximum 20 citations.

Examples of citations:
1. Pitt B, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-717.
2. Stenestrand U, Wallentin L. Swedish Register of Cardiac Intensive Care (RIKS-HIA): Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001; 285(4): 430-436.
3. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-1357.
4. Jurkovičová O, Spitzerová H, Cagáň S. Komorové arytmie a náhla srdcová smrť pri akútnom infarkte myokardu. Bratisl Lek Listy 1997; 98: 379-389.
5. Osborne BE. The electrocardiogram of the rat. In: Budden R, Detweiler DK, Zbinden G. The rat electrocardiogram in pharmacology and toxicology. Oxford: Pergamon Press 1981: 15-27.

Do not use dots after first names in citations. Do not use colon but dot after names of authors. Use semi-colon after the year of publishing, colon is before pages. If an author is one, two or three - it is necessary to state all. If there are more than three authors it is necessary to write first three and "et all".

Due to publishing of autodidactic tests it is necessary to add 4 questions to your article and 4 answers with marking of one correct answer, e.g.:

Which of following factors is not related to rosacea?
a. genetic predisposition
b. Scandinavian origin
c. propionibacterium acnes
d. endothelial growth factor

The editorial board reserves the right to make small stylistic changes in the paper. If it is necessary to shorten the paper, the consent of the author will be required. All articles are reviewed.

All published papers are paid.

Due to practical focus of the journal we would like to ask you to write the paper comprehensively, with emphasis on practical use of provided information in out-patient neurological practice.

Send contributions in the e-mail to the address: stachova@amedi.sk
Period 3x per year
1336-8621
The journal is indexed in the Slovak National Bibliography, Bibliographiia Medica Slovaca (BMS) and listed to citation database CiBaMed. All articles are reviewed. The publisher does not bear any responsibility for data and opinions of particular authors of the articles or advertisements. The articles on grey pages are company promotions or non reviewed information, an author is responsible for the content. Any reproduction of the content is allowed only with direct consent of the editorial office.
Predplatné
Neurology
Neurology
Reviewed, postgraduate scietific medical journal.
Period 3x per year